More than 30 Patient and Medical Professional Organizations Respond to US Supreme Court Decision that Protects Access to Lifesaving Preventive Care
Today, the U.S. Supreme Court issued its ruling in the case of Kennedy v. Braidwood Management.
Today, the U.S. Supreme Court issued its ruling in the case of Kennedy v. Braidwood Management.
A bill introduced earlier this year in the House and Senate now has the bipartisan support of the majority of the members in each chamber.
WASHINGTON, D.C. – Today, the president released his final proposed budget for Fiscal Year 2026 which contains $4.531 billion for the National Cancer Institute (NCI).
Legislation aimed at increasing access to breast and cervical cancer screening was introduced today in the U.S. Senate. The bipartisan Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act would reauthorize the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) for fiscal years 2026 through 2030.
New federal legislation that would make it easier for all cancer patients to participate in clinical trials was introduced today in the House of Representatives. Sponsored by U.S. Reps. Raul Ruiz (D-Calif.) and August Pfluger (R-Texas), the Clinical Trial Modernization Act would help remove cost and geographic hurdles that prevent patients from participating in clinical trials.
The U.S. House of Representatives is expected to vote on the reconciliation bill this week which includes drastic, $715 billion cuts to Medicaid that will result in at least 8.6 million people losing health insurance coverage, including cancer patients and survivors.
According to multiple news reports, Former President Joe Biden has been diagnosed with an “aggressive” form of prostate cancer that has spread to his bones.
A new survey by the American Cancer Society Cancer Action Network (ACS CAN) found that 31% of adults have been more than one year behind on cancer screenings.
Today, the American Cancer Society Cancer Action Network (ACS CAN) submitted comments in a letter to the U.S. Department of Commerce outlining concerns with instituting tariffs on pharmaceutical imports, especially for older generic sterile injectable (GSI) drugs which have been impacted by drug shortages for more than a decade.
Today, the president released his proposed budget for Fiscal Year 2026 which contains a 26.2% cut to the Department of Health and Human Services (HHS). This includes a 37% cut to the National Institutes of Health (NIH) and eliminates the National Center for Chronic Disease Prevention and Health Promotion at the Centers for Disease Control and Prevention (CDC).